Last Updated: August 11, 2026

Watson Labs Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for WATSON LABS

WATSON LABS has one thousand and thirty-three approved drugs.

There are seventeen tentative approvals on WATSON LABS drugs.

Summary for Watson Labs

US Patents:	0
Tradenames:	400
Ingredients:	377
NDAs:	1033

Drugs and US Patents for Watson Labs

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	BETHANECHOL CHLORIDE	bethanechol chloride	TABLET;ORAL	084402-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Watson Labs	SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE	hydrochlorothiazide; spironolactone	TABLET;ORAL	086026-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Watson Labs	CYCLOBENZAPRINE HYDROCHLORIDE	cyclobenzaprine hydrochloride	TABLET;ORAL	074436-001	Nov 30, 1994		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Watson Labs	TRIPROLIDINE HYDROCHLORIDE	triprolidine hydrochloride	TABLET;ORAL	085094-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Watson Labs	AFEDITAB CR	nifedipine	TABLET, EXTENDED RELEASE;ORAL	075659-001	Oct 26, 2001		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Watson Labs	BUTABARBITAL SODIUM	butabarbital sodium	TABLET;ORAL	085772-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Watson Labs Inc	CIMETIDINE	cimetidine	TABLET;ORAL	074349-001	Aug 30, 1996		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for WATSON LABS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.